Thomas J. Riga - Dec 31, 2022 Form 5 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
CEO & President, Director
Signature
/s/ Keith M. McGahan, Attorney-in-Fact for Thomas J. Riga
Stock symbol
SPPI
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/13/2023, 04:31 PM
Previous filing
Jun 23, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +240K +24.59% $0.00 1.21M Feb 14, 2022 Direct F1, F2
holding SPPI Common Stock, $0.001 par value 14.1K Dec 31, 2022 By 401(k) plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock award grant was approved by Spectrum Pharmaceuticals, Inc.'s board of directors on February 14, 2022 with an issuance date of January 14, 2022.
F2 One third of the amount of restricted shares shall vest on each of December 30, 2022, 2023 and 2024, respectively.